ethris GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ethris GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10676
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ethris GmbH (Ethris) is a biotech company that develops RNA-based therapies. The company develops therapeutics based on its proprietary platform technologies. It uses technologies including magnetovax and SNIM RNA. Ethris’ magnetovax is a platform for personalized tumor vaccines localized and activated in tumors by magnetic fields and transports nucleic acid agents. The company’s drug candidates include ETH-CFTR, ETH-CCDC40, ETH-CCNO and ETH-OTC. It partners with academic and medical institutions, and corporate biotechnology and pharmaceutical companies for its research and development activities. Ethris is headquartered in Munich, Germany.

ethris GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ethris GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ethris GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ethris GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ethris GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ethris GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ethris GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Ethris Enters into Research Agreement with Astrazeneca and MedImmune 10
Ethris Enters Into Agreement With Shire Human Genetic Therapies For RNA-Based Therapeutics 11
Licensing Agreements 12
Ethris Enters Into Licensing Agreement With Bayerische Patentallianz 12
ethris GmbH – Key Competitors 13
ethris GmbH – Key Employees 14
ethris GmbH – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
ethris GmbH, Pharmaceuticals & Healthcare, Key Facts 2
ethris GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ethris GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ethris GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ethris GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
ethris GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ethris Enters into Research Agreement with Astrazeneca and MedImmune 10
Ethris Enters Into Agreement With Shire Human Genetic Therapies For RNA-Based Therapeutics 11
Ethris Enters Into Licensing Agreement With Bayerische Patentallianz 12
ethris GmbH, Key Competitors 13
ethris GmbH, Key Employees 14

List of Figures
ethris GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ethris GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ethris GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ethris GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ethris GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ethris GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ethris GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ethris GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[ethris GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • 84 Lumber Company:企業の戦略・SWOT・財務分析
    84 Lumber Company - Strategy, SWOT and Corporate Finance Report Summary 84 Lumber Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Geistlich Pharma AG:企業の戦略的SWOT分析
    Geistlich Pharma AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • A&W Food Services of Canada Inc.:戦略・SWOT・企業財務分析
    A&W Food Services of Canada Inc. - Strategy, SWOT and Corporate Finance Report Summary A&W Food Services of Canada Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Mega Uranium Ltd (MGA):企業の財務・戦略的SWOT分析
    Mega Uranium Ltd (MGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Insightra Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Insightra Medical Inc (Insightra Medical), a subsidiary of GPB Life Science Holdings LLC is a medical device company that develops disposable devices. The company offers cardiovascular and surgical solutions. Its cardiovascular solutions include Ultra 7FR IAB and modulare. The Modulare Cathe …
  • Gordon Ramsay Holdings Limited:企業の戦略・SWOT・財務情報
    Gordon Ramsay Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Gordon Ramsay Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Avalara Inc:企業のM&A・事業提携・投資動向
    Avalara Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Avalara Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • FIncantieri SpA:企業の戦略・SWOT・財務情報
    FIncantieri SpA - Strategy, SWOT and Corporate Finance Report Summary FIncantieri SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Allan Myers Inc:企業の戦略・SWOT・財務分析
    Allan Myers Inc - Strategy, SWOT and Corporate Finance Report Summary Allan Myers Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Visteon Corporation:企業の戦略・SWOT・財務情報
    Visteon Corporation - Strategy, SWOT and Corporate Finance Report Summary Visteon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • AcelRx Pharmaceuticals Inc (ACRX):製薬・医療:M&Aディール及び事業提携情報
    Summary AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain. The company’s lead product candidate, Dsuvia (known as Dzuveo outside the US), is a single sufentanil sublingual tablet for the treatment of moderate-t …
  • Kering SA (KER):企業の財務・戦略的SWOT分析
    Kering SA (KER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • AusGroup Ltd (5GJ):石油・ガス:M&Aディール及び事業提携情報
    Summary AusGroup Ltd (AusGroup) is a provider of project and asset services. The company operates through its subsidiaries, namely, MAS, AGC, and NT Port and Marine. Its major services include mechanical and piping, scaffolding, multidisciplinary maintenance services, fabrication & management, surfa …
  • The Walt Disney Company:企業の戦略・SWOT・財務分析
    The Walt Disney Company - Strategy, SWOT and Corporate Finance Report Summary The Walt Disney Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Scholar Rock Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Scholar Rock Inc (Scholar Rock), a subsidiary of Scholar Rock Holding Corp, is a biopharmaceutical company that discovers and develops novel medicines for serious unmet medical needs. Its proprietary technology platform develops new medicines, modulating supracellular activation, for the app …
  • Santander Private Bank:企業の戦略・SWOT・財務分析
    Santander Private Bank - Strategy, SWOT and Corporate Finance Report Summary Santander Private Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Herantis Pharma Plc (HRTIS):医療機器:M&Aディール及び事業提携情報
    Summary Herantis Pharma Plc (Herantis Pharma) is a drug development company that offers regenerative medicine for neurodegenerative diseases. The company's pipeline products include CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson’s disease and lymfactin for secondary lymphedema. Its lymfa …
  • Dana Brevini Spa:企業の戦略・SWOT・財務分析
    Dana Brevini Spa - Strategy, SWOT and Corporate Finance Report Summary Dana Brevini Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • CPFL Energia SA:発電所・企業SWOT分析
    CPFL Energia SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • Enerjisa Enerji Uretim AS:企業の発電所・SWOT分析2018
    Enerjisa Enerji Uretim AS - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆